학술논문
Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial
Document Type
Article
Author
Source
In The Lancet Diabetes & Endocrinology February 2023 11(2):109-119
Subject
Language
ISSN
2213-8587